Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Glioblastoma Multiforme Vaccine Trial
Clinical Trial Protocol ID
11090803

Clinical Trial Investigator Name
Robert Aiken

Clinical Trial Title

DC Vax-Brain



Clinical Trial Protocol Description

Vaccine trial for the treatment of glioblastoma multiforme, administered in conjunction with temozolomide and radiation therapy, which is the current, accepted standard of care.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this study if you:

  • Are 18 to 70 years of age
  • Have a life expectancy greater than eight weeks
  • Are willing to consent to tumor tissue sampling prior to surgery
  • Have a tumor that is unilateral and may involve, but not cross, the corpus callosum

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.





Contact Name Suzanne Matney
Contact Phone (312) 942-2388
Contact E-mail clinical_trials@rush.edu
Promotional Information

Clinical Trials Home
Neurological Disorders Trials
Cancer Clinical Trials
Glioblastoma Multiforme Vaccine Trial

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois